DARE: Daré Bioscience, Inc. Stock

by  •  • Comments Off on DARE: Daré Bioscience, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 29.00
Enterprise Value ($M) 22.26
Book Value ($M) -1.48
Book Value / Share -0.17
Price / Book -19.54
NCAV ($M) -4.60
NCAV / Share -0.53
Price / NCAV -6.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.82
Return on Assets (ROA) -0.14
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.14
Current Ratio 1.14

Balance Sheet (mrq) ($M)
Current Assets 14.95
Assets 18.06
Liabilities 19.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-25 8,135 35,916 22.65
2024-11-22 7,614 29,340 25.95
2024-11-21 16,288 51,758 31.47
2024-11-20 3,605 20,402 17.67

(click for more detail)

Similar Companies
CYCN – Cyclerion Therapeutics, Inc. CYRX – Cryoport, Inc.
CYTH – Cyclo Therapeutics, Inc. DERM – Journey Medical Corporation
DMAC – DiaMedica Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io